Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04706533 · ClinicalTrials.gov registry record
Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19
A clinical trial of Inflammation and Covid19, sponsored by University of Michigan.
- Completed
- Registry status
- 3,402
- Enrollment target
- 1
- Study location
NCT04706533 is a study of Inflammation and Covid19 that has completed, run by University of Michigan. The registered enrollment target is 3,402 participants, above the 262-participant average among 132 other Inflammation trials with a reported enrollment target (1198% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04706533, a study of Inflammation and Covid19, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 3,402 participants
- Enrollment target
- 1
- Study location
Study Summary
To better understand the role of inflammation in COVID-19, we established the Michigan Medicine COVID-19 Cohort (M2C2). M2C2 is a funded and ongoing cohort which has currently enrolled over 1500 adult patients (≥18 years) with severe COVID-19 admitted at the University of Michigan. The purpose of M2C2 is to define the in-hospital course of these patients and understand the role of inflammation as a determinant of organ injury and outcomes in COVID-19.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Biomarkers of inflammation
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,402 participants |
| Start Date | 2020-03-23 |
| Est. Completion | 2022-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04706533
The ClinicalTrials.gov registry entry for NCT04706533 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,402 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 262-participant average among 132 other Inflammation trials with a reported enrollment target (1198% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 1 intervention - of which Biomarkers of inflammation is the first listed.
NCT04706533 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT04706533 about?
NCT04706533 is a clinical study titled "Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19". To better understand the role of inflammation in COVID-19, we established the Michigan Medicine COVID-19 Cohort (M2C2). M2C2 is a funded and ongoing cohort which has currently enrolled over 1500 adult patients (≥18 years) with severe COVID-19 admitted at the University of Michigan. The purpose of M2...
What is the current status of trial NCT04706533?
This trial is currently completed. The enrollment target is 3,402 participants. The study started on 2020-03-23. Estimated completion is 2022-12-01.
What conditions does trial NCT04706533 study?
This clinical trial studies the following conditions: Inflammation, Covid19, Kidney Diseases, SARS-CoV Infection.
What interventions are being tested in trial NCT04706533?
The interventions under investigation include: Biomarkers of inflammation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04706533?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04706533 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RECRUITING · Phase 3
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.